Together, the aforementioned results confirmed our hypothesis that low-dose sucrose intervention alleviated DSS-induced colitis in mice by restoring microbial dysfunction, promoting the production of SCFAs, and activating the PPAR-γ/MAPK/NF-κB signaling pathway. This evidence concerns the gene PPARG and colitis.